Granules India Ltd. shows moderate growth and profitability metrics compared to its peers in the Pharmaceuticals & Drugs sector, with certain areas of concern, particularly in revenue growth. The sector features strong performers like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. which exhibit solid growth and profitability, while Granules appears to be undervalued relative to its peers. Overall, while Granules has potential, it is overshadowed by stronger competitors.

• • Granules India Ltd. has low revenue growth and average profitability compared to peers.
• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. are leading in profitability and growth metrics.
• • Granules is undervalued with a low PE ratio compared to its profitability, presenting a potential investment opportunity.